Tag Archives: China

2013 BIO Convention in China Facilitates East-West Partnering in Biotech

biochina-flag-btn

Now in its third year, the BIO Convention in China will be held November 11-13, 2013 in Beijing, China. A sister event to the BIO International Convention, BIO China will bring together executives from biotechnology, pharmaceutical companies and investment firms from North America, Europe and Asia to meet and explore business opportunities in China, where the Rx market is poised to grow to $315 billion in 2020. For Western companies and investors looking to capitalize Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,

Chinese In-Licensing Continues to Strengthen

Chinese companies are eager to collaborate with their ex-China counterparts, and in-licensing agreements are outpacing other forms of biotech deal-making in 2013. In fact, the number of in-licensing deals announced so far this year is more than the combined number of 2012 deals in out-licensing, JV/Alliance and M&A, according to BIO’s Industry Analysis research and GBI. This deal-making momentum bodes well for small and medium-sized biotech companies that have early-stage compounds under development in the Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , ,

China’s Biotech Innovators

As the Chinese government implements policies aimed at increasing innovation in the life sciences industry, a new breed of domestic Chinese companies are structuring their corporate infrastructure to amplify innovation. Three themes are emerging from these innovative Chinese companies: the development of new business models, partnering with Western entities, and placing Chinese citizens at the helm that have advanced degrees and industrial experience from the West. As an example, consider the management and business model Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , ,

Everyone is Engaging with China’s Biotech Industry, Including BIO

biochina-flag-btn

Countries all over the world are recognizing the importance of biotechnology to their economies, the health and well-being of their citizens, their food supply and their ability to generate clean energy. Nearly every major country has adopted programs to generate a homegrown biotechnology sector and the well-paying jobs it supports. China is no exception. China has included biotechnology as one of seven strategic priorities for scientific and technological development in its 12th Five-Year Plan and Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Spotlight on China

Cho

The 20th annual BIO International Convention is wrapping up in Chicago. Experts and leaders from leading global biotechnology, biologics and investment companies gathered together to discuss the opportunities and challenges in the biologics industry. A large China Food and Drug Administration (CFDA) delegation led by Deputy Commissioner Bian Zhenjia participated in a half-day session dedicated to developing a world-class therapeutic biologics industry in China. There has been a shift in recent years in the usage Read More >

Business and Investments  |  1 Comment  |  Email This Post
Tags: , , , ,